Table 2. Prevalence of CAD, comorbidities, coronary and aortic calcifications, stratified by cancer laterality.
| Clinical and imaging characteristics | Total cohort (n=546) (%) | Right (n=261) (%) | Left (n=285) (%) | P |
|---|---|---|---|---|
| Clinical CAD (MI/PCI/CABG) | 13 | 18 | 8.1 | <0.001 |
| Prior MI | 11 | 16.1 | 6.3 | |
| History of PCI/CABG | 10 | 13.4 | 7.7 | |
| Hypertension | 50 | 56.3 | 43.5 | 0.003 |
| Diabetes mellitus | 17 | 17.2 | 16.5 | 0.815 |
| Hyperlipidemia | 34 | 41.0 | 27.0 | 0.001 |
| Hypothyroidism | 8 | 11.5 | 4.6 | 0.003 |
| Congestive heart failure | 5 | 7.3 | 3.5 | 0.050 |
| Atrial fibrillation | 10 | 11.5 | 8.1 | 0.177 |
| Chronic kidney disease | 4 | 5.0 | 3.2 | 0.279 |
| CT imaging data* | ||||
| Any calcifications | 67.3 | 79.1 | 56.4 | 0.033 |
| Coronary artery | 49 | 62.4 | 36.9 | <0.001 |
| Thoracic aorta | 53 | 66.5 | 41.1 | <0.001 |
| Abdominal aorta | 60 | 72.2 | 48.6 | <0.001 |
*, total cohort n=486, right n=230, left n=256. CAD, coronary artery disease; PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting.